TyRx Pharma, Inc. was focused on developing implantable combination drugdevice products utilizing novel biomaterials. Additionally, TyRx has exclusively licensed from Baylor College of Medicine and The University of Texas M. D. Anderson Cancer Center product patents and associated technologies to address the problem of post surgical nosocomial infection. TyRx was deploying its capabilities across a broad range of combination implantable medical-pharmaceutical devices. TyRx was acquired by Medtronic in 2011.
Seed-One Managing Partner Jeff Wolf co-founded Tyrx and served as its Chairman.
Member count: 51-200
Total raised: $20M
Founded date: 1998
Investors 1
| Date | Name | Website |
| - | Seed-One C... | seedone.co... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 08.12.2010 | - | $20M | - | finsmes.co... |
Mentions in press and media 8
| Date | Title | Description | Category | Author | Source |
| 31.10.2016 | How J&... | The Affordable Care Act has la... | - | - | medcitynew... |
| 26.10.2016 | Spinal rod... | ” I had not been tracking that... | - | - | medcitynew... |
| 09.07.2013 | FDA Clears... | Share Share on Facebook Share ... | - | Ben Fidler | xconomy.co... |
| 12.10.2011 | In-hospita... | Healthcare-associated infectio... | - | - | medcitynew... |
| 08.12.2010 | TYRX Raise... | TYRX, Inc., a Monmouth Junctio... | funding U... | - | finsmes.co... |
| - | How J&... | The Affordable Care Act has la... | - | - | medcitynew... |
| - | Spinal rod... | Spinal rods from Medicrea now ... | - | - | medcitynew... |
| - | In-hospita... | A report by the Pennsylvania D... | - | - | medcitynew... |